| 摘要 |
A method useful for the treatment or prevention of diseases caused by a massive release of cerebral glutamate, in particular epilepsy, Altzheimer's disease and Huntington's chorea, and pharmaceutical formulations therefor, which comprise, as an active ingredient, a therapeutically effective amount of methyl (+)-(4S)-4,7 dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl) thieno¢2,3-b!pyridine-5-carboxylate (S-312-d).
|
